Drugs by condition
Drugs approved for cystic fibrosis
Last checked: Nov 20, 2026Source: FDA labels (openFDA), Drugs@FDAMethods & limitations
Brand-name drugs approved
18
Still marketed, NDA or BLA
Drug classes
4
Novel drugs
7
New molecular entities and new biologics
In development
15
Investigational drugs in Phase 2 or 3
Newest approvals
The most recently first-approved brand-name drugs for cystic fibrosis.
- Brinsupri (Brensocatib) · Insmed INC NovelBreakthrough therapyPriority reviewAug 12, 2025
- Alyftrek (Deutivacaftor, Tezacaftor, Vanzacaftor Calcium) · Vertex Pharms INC NovelPriority reviewOrphanDec 20, 2024
- Trikafta (Copackaged) (Elexacaftor, Ivacaftor, Tezacaftor, Ivacaftor) · Vertex Pharms INC Priority reviewOrphanApr 26, 2023
- Trikafta (Copackaged) (Elexacaftor, Ivacaftor, Tezacaftor, Ivacaftor) · Vertex Pharms INC NovelBreakthrough therapyPriority reviewOrphanOct 21, 2019
- Orkambi (Ivacaftor, Lumacaftor) · Vertex Pharms INC Breakthrough therapyPriority reviewOrphanAug 7, 2018
All approved drugs for cystic fibrosis, by class
Every marketed NDA or BLA whose current FDA label names this condition in its Indications and Usage section, plus 60 generic labels. A drug can be approved for only part of a condition (one subtype or stage, or as add-on therapy), so check its label.
Cystic Fibrosis Transmembrane Conductance Regulator Potentiator (5)
Aminoglycoside Antibacterial (4)
- Kitabis Pak Tobramycin · Pulmoflow INC · 2014
- Tobi Podhaler Tobramycin · Viatris · 2013
- Bethkis Tobramycin · Chiesi · 2012
- Tobi Tobramycin · Viatris · 1997
Recombinant Human Deoxyribonuclease 1 (1)
- Pulmozyme Dornase Alfa · Genentech · 1993
Class not listed in FDA's data (8)
- Brinsupri Brensocatib · Insmed INC · 2025
- Trikafta (Copackaged) Elexacaftor, Ivacaftor, Tezacaftor, Ivacaftor · Vertex Pharms INC · 2019
- Symdeko (Copackaged) Ivacaftor, Ivacaftor, Tezacaftor · Vertex Pharms INC · 2018
- Trikafta (Copackaged) Elexacaftor, Ivacaftor, Tezacaftor, Ivacaftor · Vertex Pharms INC · 2023
- Cayston Aztreonam · Gilead · 2010
- Zithromax Azithromycin · Pfizer · 2002
- Zithromax Azithromycin · Pfizer · 1996
- Zithromax Azithromycin · Pfizer · 1995
Drugs in development for cystic fibrosis
Investigational drugs FDA has not approved, in active or recent industry-sponsored Phase 2 and 3 trials for this condition. Phase 3 first.
- HSK31858Phase 33 trials
Haisco Pharmaceutical Group Co., Ltd. · Non-cystic Fibrosis Bronchiectasis, Asthma Bronchiale, Bronchiectasis
- VX-121D-IVA, CTP-656Phase 33 trials
Vertex Pharmaceuticals · Cystic Fibrosis
- GalvokimigUCB9741Phase 23 trials
UCB · Chronic Obstructive Pulmonary Disease With Chronic Bronchitis, Atopic Dermatitis, Non-cystic Fibrosis Bronchiectasis
- ANG003Phase 21 trial
Anagram Therapeutics, Inc. · Exocrine Pancreatic Insufficiency (EPI), Cystic Fibrosis (CF)
- ARCT-032Phase 21 trial
Arcturus Therapeutics, Inc. · Cystic Fibrosis, CFTR Gene Mutation
- BX004Combination of nebulized bacteriophages targeting Pseudomonas aeruginosaPhase 21 trial
BiomX Ltd · Chronic Pseudomonas Aeruginosa Infection, Cystic Fibrosis (CF)
- CMTX-101Phase 21 trial
Clarametyx Biosciences, Inc. · Persistent Infection, Cystic Fibrosis
- CSL787Phase 21 trial
CSL Behring · Non-cystic Fibrosis Bronchiectasis
- ETD001Phase 21 trial
Enterprise Therapeutics Ltd · Cystic Fibrosis
- NHS7108Phase 21 trial
Aimmune Nestlé Health Science US R&D, LLC · Exocrine Pancreatic Insufficiency (EPI), Cystic Fibrosis (CF), Pancreatic Enzyme Abnormality
- RCT2100Phase 21 trial
ReCode Therapeutics · Cystic Fibrosis
- RESP302Phase 21 trial
Thirty Respiratory Limited · Non-Cystic Fibrosis Bronchiectasis
- RESP303Phase 21 trial
Thirty Respiratory Limited · Non-Cystic Fibrosis Bronchiectasis
- RSP-1502Phase 21 trial
Respirion Pharmaceuticals Pty Ltd · Cystic Fibrosis Lung, Respiratory Infections, Recurrent, Chronic, Pseudomonas Aeruginosa
- SPL84Phase 21 trial
SpliSense Ltd. · Cystic Fibrosis
More on cystic fibrosis: recruiting trials · published research
Related in respiratory: Pulmonary arterial hypertension · Asthma · COPD · Idiopathic pulmonary fibrosis · Allergies (allergic rhinitis)
For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.